RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CORT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Corcept Therapeutics Incorporated stock price down 0.513% on Thursday
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 12, 2024 Gain 2.98% PDF

The Corcept Therapeutics Incorporated stock price fell by -0.513% on the last day (Thursday, 28th Mar 2024) from $25.32 to $25.19. During the last trading day the stock fluctuated 1.98% from a day low at $25.19 to a day high of $25.69. The price has risen in 6 of the last 10 days and is up by 6.42% over the past 2 weeks. Volume has increased on the last day by 40 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 754 thousand shares were bought and sold for approximately $18.99 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Corcept Therapeutics Incorporated stock with a 90% probability to be traded between $20.31 and $31.27 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CORT Signals & Forecast

The Corcept Therapeutics Incorporated stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $24.80 and $23.74. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, January 31, 2024, and so far it has risen 19.38%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Corcept Therapeutics Incorporated stock

Corcept Therapeutics Incorporated finds support from accumulated volume at $24.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.500 (1.98%) between high and low. For the last week, the stock has had daily average volatility of 2.57%.

Our recommended stop-loss: $24.51 (-2.68%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 40 days ago.)

Trading Expectations (CORT) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Corcept Therapeutics Incorporated to open at $25.36, and during the day (based on 14 day Average True Range), to move between $24.27 and $26.11, which gives a possible trading interval of +/-$0.92 (+/-3.66%) up or down from last closing price. If Corcept Therapeutics Incorporated takes out the full calculated possible swing range there will be an estimated 7.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $25.34 (0.60%) than the support at $24.16 (4.09%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Corcept Therapeutics Incorporated stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Corcept Therapeutics Incorporated stock to perform well in the short-term period.

Current score: 3.116 Buy Candidate Unchanged

Predicted Opening Price for Corcept Therapeutics Incorporated of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$25.36 ( 0.662%) $25.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CORT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 25.86 2.65 %
R2 25.67 1.89 %
R1 25.55 1.42 %
Current price: 25.19
Support S1 25.17 -0.0966 %
S2 25.05 -0.565 %
S3 24.86 -1.32 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 27.46 9.01 %
R2 25.39 0.794 %
R1 25.34 0.595 %
Current price 25.19
Support S1 24.16 -4.09%
S2 23.56 -6.47%
S3 21.66 -14.01%

FAQ

What is the symbol for Corcept Therapeutics Incorporated Stock and on which exchange is it traded?
The symbol for Corcept Therapeutics Incorporated is CORT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Corcept Therapeutics Incorporated Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Corcept Therapeutics Incorporated stock to perform well in the short-term period.

How to buy Corcept Therapeutics Incorporated Stock?
Corcept Therapeutics Incorporated Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Corcept Therapeutics Incorporated Stock.

What's the current price of Corcept Therapeutics Incorporated Stock?
As of the end of day on the 2024-03-28, the price of an Corcept Therapeutics Incorporated (CORT) share was $25.19.

What is the 52-week high and low for Corcept Therapeutics Incorporated Stock?
The 52-week high for Corcept Therapeutics Incorporated Stock is $34.28 and the 52-week low is $20.87.

What is the market capitalization of Corcept Therapeutics Incorporated Stock?
As of the 2024-03-28, the market capitalization of Corcept Therapeutics Incorporated is 2.608B.

When is the next earnings date for Corcept Therapeutics Incorporated?
The upcoming earnings date for Corcept Therapeutics Incorporated is May 01, 2024.
Click to get the best stock tips daily for free!

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT